Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiichiro Fujisaki

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Renal Failure|January 30, 2016
Erythropoiesis-stimulating agent slows the progression of chronic kidney disease: a possibility of a direct action of erythropoietinKazuhiko Tsuruya, Hisako Yoshida, Takaichi Suehiro, et al.
Plos One|December 4, 2015
Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP StudyKazuhiko Tsuruya, Hisako Yoshida, Naoki Haruyama, et al.
Kidney International Reports|February 22, 2021
Pre-dialysis Hyponatremia and Change in Serum Sodium Concentration During a Dialysis Session Are Significant Predictors of Mortality in Patients Undergoing HemodialysisKiichiro Fujisaki, Nobuhiko Joki, Shigeru Tanaka, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|February 21, 2007
Midodrine hydrochloride and L-threo-3,4-dihydroxy-phenylserine preserve cerebral blood flow in hemodialysis patients with orthostatic hypotensionKiichiro Fujisaki, Hidetoshi Kanai, Hideki Hirakata, et al.
Kidney International Reports|June 20, 2024
Association Between Disturbed Serum Phosphorus Levels and QT Interval ProlongationSho Sasaki, Kiichiro Fujisaki, Masato Nishimura, et al.
Stroke|August 11, 2016
Association Between Serum Phosphate Levels and Stroke Risk in Patients Undergoing Hemodialysis: The Q-Cohort StudyShunsuke Yamada, Kazuhiko Tsuruya, Masatomo Taniguchi, et al.
Case Reports in Medicine|May 30, 2017
Asymptomatic Brain Edema after Hemodialysis Initiation in a Patient with Severe UremiaKiichiro Fujisaki, Kaneyasu Nakagawa, Hiroshi Nagae, et al.
Nephron|June 8, 2018
Study on Dialysis Session Length and Mortality in Maintenance Hemodialysis Patients: The Q-Cohort StudyKiichiro Fujisaki, Shigeru Tanaka, Masatomo Taniguchi, et al.
Plos One|February 22, 2021
Added value of clinical prediction rules for bacteremia in hemodialysis patients: An external validation studySho Sasaki, Yoshihiko Raita, Minoru Murakami, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 7, 2026
Association of Serum Phosphorus Levels With QT Prolongation in Patients With End-Stage Kidney Disease: Insights From the Analysis of Peritoneal Dialysis PatientsSho Sasaki, Kiichiro Fujisaki, Hikaru Uematsu, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Renal Failure|January 30, 2016
Erythropoiesis-stimulating agent slows the progression of chronic kidney disease: a possibility of a direct action of erythropoietinKazuhiko Tsuruya, Hisako Yoshida, Takaichi Suehiro, et al.
Plos One|December 4, 2015
Clinical Significance of Fronto-Temporal Gray Matter Atrophy in Executive Dysfunction in Patients with Chronic Kidney Disease: The VCOHP StudyKazuhiko Tsuruya, Hisako Yoshida, Naoki Haruyama, et al.
Kidney International Reports|February 22, 2021
Pre-dialysis Hyponatremia and Change in Serum Sodium Concentration During a Dialysis Session Are Significant Predictors of Mortality in Patients Undergoing HemodialysisKiichiro Fujisaki, Nobuhiko Joki, Shigeru Tanaka, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|February 21, 2007
Midodrine hydrochloride and L-threo-3,4-dihydroxy-phenylserine preserve cerebral blood flow in hemodialysis patients with orthostatic hypotensionKiichiro Fujisaki, Hidetoshi Kanai, Hideki Hirakata, et al.
Kidney International Reports|June 20, 2024
Association Between Disturbed Serum Phosphorus Levels and QT Interval ProlongationSho Sasaki, Kiichiro Fujisaki, Masato Nishimura, et al.
Stroke|August 11, 2016
Association Between Serum Phosphate Levels and Stroke Risk in Patients Undergoing Hemodialysis: The Q-Cohort StudyShunsuke Yamada, Kazuhiko Tsuruya, Masatomo Taniguchi, et al.
Case Reports in Medicine|May 30, 2017
Asymptomatic Brain Edema after Hemodialysis Initiation in a Patient with Severe UremiaKiichiro Fujisaki, Kaneyasu Nakagawa, Hiroshi Nagae, et al.
Nephron|June 8, 2018
Study on Dialysis Session Length and Mortality in Maintenance Hemodialysis Patients: The Q-Cohort StudyKiichiro Fujisaki, Shigeru Tanaka, Masatomo Taniguchi, et al.
Plos One|February 22, 2021
Added value of clinical prediction rules for bacteremia in hemodialysis patients: An external validation studySho Sasaki, Yoshihiko Raita, Minoru Murakami, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|July 7, 2026
Association of Serum Phosphorus Levels With QT Prolongation in Patients With End-Stage Kidney Disease: Insights From the Analysis of Peritoneal Dialysis PatientsSho Sasaki, Kiichiro Fujisaki, Hikaru Uematsu, et al.
Pageof 4